Lotus Pharmaceutical Competitors and Similar CompaniesClear all
Lotus Pharmaceutical's competitors and similar companies include Tanvex BioPharma, Pharmaron, SeQuent Scientific and Polpharma Biologics.
 Lotus Pharmaceutical Lotus Pharmaceutical (美時化學製藥股份有限公司) is a company that develops, manufactures, and markets pharmaceutical products. |  Tanvex BioPharma Tanvex BioPharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs. |  Pharmaron Pharmaron (康龙化成(北京)新药技术股份有限公司) is a company that provides drug research, development, and manufacturing services for the life sciences industry. |  SeQuent Scientific SeQuent Scientific (formerly PI Drugs and Pharmaceuticals) is a pharmaceutical company active in the animal health sector and contract research focusing on analytical and bioanalytical services. | ||
Founding Date | Founding Date 1966 | Founding Date 2013 | Founding Date 2004 | Founding Date 2002 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Taipei City, TW HQ Singapore, SG Ho Chi Minh City, VN | Locations Taipei, TW HQ New Taipei, TW Irvine, US San Diego, US San Diego, US | Locations Thane, IN HQ Jigani, IN Mangalore, IN | Locations Warsaw, PL HQ Amsterdam, NL Utrecht, NL Gdańsk, PL | |
Employees | Employees 66911% increase | Employees 13827% decrease | Employees 21,370 | Employees 1,195 | Employees 1,0691% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) NT$20.5b (FY, 2025) | Revenue (est.) NT$401m (FY, 2025) | Revenue (est.) ¥13.9b (FY, 2025) | Revenue (est.) ₹15.5b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods NT$7b (FY, 2025) | Cost of goods NT$466.3m (FY, 2025) | Cost of goods ¥9.2b (FY, 2025) | Cost of goods ₹8.3b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit NT$13.6b (FY, 2025) | Gross profit (NT$10.6m) (FY, 2025) | Gross profit ¥4.8b (FY, 2025) | Gross profit ₹7.3b (FY, 2025) | Gross profit N/A |
Net income | Net income NT$4.7b (FY, 2025) | Net income (NT$1.5b) (FY, 2025) | Net income ¥1.6b (FY, 2025) | Net income ₹322.6m (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 346.9m | Total funding raised $ 909m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Tanvex BioPharma
HQ
Taipei, TW
Employees
138↓ 27% decrease
Tanvex BioPharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs.
View companyPharmaron
HQ
Beijing, CN
Employees
21,370
Pharmaron (康龙化成(北京)新药技术股份有限公司) is a company that provides drug research, development, and manufacturing services for the life sciences industry.
View companySeQuent Scientific
HQ
Thane, IN
Employees
1,195
SeQuent Scientific (formerly PI Drugs and Pharmaceuticals) is a pharmaceutical company active in the animal health sector and contract research focusing on analytical and bioanalytical services.
View company
Polpharma Biologics
HQ
Warsaw, PL
Polpharma Biologics is a company that provides biopharmaceutical services.
View company